OpGen Inc Announces David Lazar as New CEO
Company Announcements

OpGen Inc Announces David Lazar as New CEO

The latest update is out from OpGen Inc (OPGN).

OpGen, Inc. has appointed David Lazar as its new CEO, effective April 1, 2024, with an annual salary of $406,000, to be deferred until the company’s liquidity allows for payment. Lazar, who has extensive leadership experience including a role as CEO of Titan Pharmaceuticals and board positions at several companies, will also be eligible for various bonuses. His term is set for three years, and he currently serves as OpGen’s Chairman of the Board, bringing a wealth of experience as a custodian and advisor in diverse industries.

Learn more about OPGN stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskOpGen’s Strategic Moves Amid Nasdaq Delisting and New Financing
TipRanks Auto-Generated NewsdeskOpGen Bolsters Board with Five New Industry Experts
TipRanks Auto-Generated NewsdeskOpGen Leadership Changes: CEO Resigns, New Chairman Appointed
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App